Inter Parfums, Inc. (IPAR)
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$116.69+2.35%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · IPAR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $117 the market pays 22× p/e — above the 17× p/e peer median but in line with its own 19× history. That premium reflects a durable franchise our peer-anchored $98 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $120–$151. Note: our $98 fair value sits below the entire analyst range ($120–$151). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $135.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $188.91 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $357.71 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $56.28 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$120.00 – $151.00 (median $135.50) · 6 analysts · as of 2026-08-14
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 20% over what the business is worth with no growth; closing that gap needs roughly 11.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $5.42/sh owner earnings.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $63.31 |
| — |
| — |
| TTM |
| high |
| Peer EV/EBITDA | 12M | $116.26 | 11.8 | 9.85 | TTM | high |
| Peer P/FCF | 12M | $120.40 | 15.6 | 7.71 | TTM | high |
| Peer P/E | 12M | $79.74 | 15.6 | 5.10 | ntm analyst | high |
| Peer P/S | 12M | $40.02 | 0.9 | 46.89 | TTM | high |
| residual income | 12M | $43.41 | — | — | TTM | high |
| Own P/E history | 12M | $101.01 | 19.3 | 5.23 | TTM | high |
| triangulated | 12M | $92.84 | 16.8 | 5.52 | Triangulated | high |
| Peer P/FCF | 3Y | $183.12 | 15.6 | 11.72 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $77.46 | 15.6 | 4.96 | Analyst | medium |
| Peer P/S | 3Y | $41.57 | 0.9 | 48.70 | guidance | medium |
| Own P/E history | 3Y | $99.87 | 19.3 | 5.17 | Analyst | medium |
| Peer P/FCF | 5Y | $242.18 | 15.6 | 15.50 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $75.24 | 15.6 | 4.82 | Analyst | high |
| Peer P/S | 5Y | $40.38 | 0.9 | 47.31 | guidance | high |
| Own P/E history | 5Y | $99.12 | 19.3 | 5.13 | Analyst | high |